Nephrology & Transplantation Update Course

NEPHROLOGY & TRANSPLANTATION UPDATE COURSE
28th & 29th November 2020

GENERAL NEPHROLOGY

TRANSPLANTATION

ASTELLAS
2020 THEME SPONSORS

Registration to the online Nephrology & Transplantation Update Course includes access to the full program below, the Meeting Hub, Exhibition Lounge and all virtual networking sessions.  

ANZSN aims to provide most sessions on-demand to registered delegates for a four week period after the event.  Availability of recorded sessions for on-demand will be dependent on consent received from presenters.  Where consent has not been received and the session will only be available live on the day of presentation this will be indicated in the program below by 30th October 2020.

Registration to the Update Course is separate to the main ANZSN ASM and is an additional cost to attend. 

Click here to register.

Program times are listed in AEST. To convert program times to your timezone, CLICK HERE

Saturday, 28th November 2020

0830-0900
SPEED NETWORKING ICEBREAKER
Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Participants will be randomly allocated through a series of four-person 4 minute video chats.  You never know who you might meet!

0900-1145
ADVANCES IN NEPHROLOGY IN 2020

At the dawn of 2020, Nephrology fields have made several breakthroughs that include but not limited to the followings: 1) After nearly two decades, a new agent, sodium–glucose cotransporter 2 (SGLT2) inhibitor is proven to prevent loss of kidney function, end-stage kidney disease, hospitalisation for heart failure and cardiovascular death in patients with Diabetic Kidney Disease (DKD); 2) New discovery has provided an approved treatment to slow the growth of cysts and to preserve kidney function of the most common inherited kidney disease, Autosomal Dominant Polycystic Kidney Disease (ADPKD), 3) Several milestones have been made in management of anemia in Chronic Kidney Disease (CKD) with emerging efficacy and safety evidence of orally available HIF-1a stabilizers, 4) Technical advances in genome sequencing and association studies have yielded critical insights into the genetic architecture of kidney diseases that improve our understanding of the mechanisms of kidney development, homeostasis and disease states, many of which have clinical implications.

Learning objective(s):

  • To promote understanding and clinical knowledge in the recent advances in the field of nephrology.
  • To outline the current available evidence and gaps in knowledge with the view to promote future research.
0900-0905 WELCOME
Muh Geot Wong, Nephrology & Transplantation Update Course Chair

0905-0930 ADVANCE IN MANAGEMENT OF DIABETIC KIDNEY DISEASE (DKD)

Meg Jardine, Nephrologist, Concord Repatriation Hospital, The George Institute and UNSW Sydney

0935-1005 ADVANCE IN MANAGEMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE (CKD)

Simon Roger, Nephrologist, University of Newcastle and Gosford Hospital

1005-1035 NEW KIDNEY IMAGING TECHNIQUES – READY FOR CLINICAL USE?

Patrick (Paddy) Mark, Consultant Nephrologist, Queen Elizabeth University Hospital Glasgow

1035-1105 ADVANCES IN GENETICS IN NEPHROLOGY

Amali Mallawaarachchi, Nephrologist, Royal Prince Alfred Hospital

1105-1135 BREAKTHROUGH IN MANAGEMENT OF PKD – ADPKD AND ARPKD

Lisa Guay-Woodford, Nephrologist, Children’s National Medical Center (CNMC), Washington

1145-1215 EXHIBITION & REFRESHMENT BREAK
Visit our sponsors in the Exhibition Lounge or catch up with colleagues through the Meeting Hub
1215-1545
GENERAL NEPHROLOGY
With the program going completely virtual in 2020, we have created 5 concurrent sessions providing the latest updates in general nephrology under the following five subthemes. A mixture of local, regional and international speakers will cover topics that are bread and butter for your clinical practice including glomerulonephritis, acute and chronic kidney disease as well as the hot topic of COVID-19 and the kidneys. The second half of the Interventional Nephrology (combined ANZSIN-ANZSN) and Genetic / Paediatric (Combined KidGen-ANZSN sessions) consist of interactive workshops facilitate by the field experts giving you the best experience in translation medicine.

Don’t stress if you can’t attend every session. All sessions (unless otherwise indicated) will be recorded and shared with participants after the course.
1215-1355
CONCURRENT SESSIONS

Each sessions consists of minimum three speakers and includes question time.  Participants may attend any session without pre-booking.  All presentations, unless otherwise indicated, will be available on-demand to registered participants for a limited time after the course.
GLOMERULONEPHRITIS ACUTE KIDNEY INJURY AND ELECTROLYTES CHRONIC KIDNEY DISEASE INTERVENTIONAL NEPHROLOGY – ANZSIN / ANZSN combined session PAEDIATRIC / GENETIC NEPHROLOGY – KidGen / ANZSN combined session
1215-1220 CHAIR INTRODUCTION
Muh Geot Wong
1215-1220 CHAIR INTRODUCTION
Robert MacGinley
1215-1220 CHAIR INTRODUCTION
Rob Walker
1215-1220 CHAIR INTRODUCTION
Eddie Tan
1215-1220 CHAIR INTRODUCTION
Catherine Quinlan

1220-1250 UPDATE IN LUPUS NEPHRITIS

Daniel Chan, Nephrologist, Chief of Nephrology Division. Chief of Nephrology, University of Hong Kong and Hong Kong West Cluster Hospitals

1220-1250 THE GREAT IV FLUID DEBATE: SHOULD WE AVOID (AB)NORMAL SALINE AND SEEK MORE BALANCE?

Michael Collins, Nephrologist, Auckland District Health Board

1220-1250 DOSE AND FREQUENCY OF DIALYSIS – WHICH IS MORE IMPORTANT?

Lorraine Kwan, Nephrologist, Queen Mary Hospital and Tung Wah Hospital

[APSN Speaker]

1220-1250 UPDATE IN HD ACCESS IN 2020

Andrea Viecelli, Nephrologist, Princess Alexandra Hospital and University of Queensland

1220-1250 HYPERTENSION AND PROGRESSION OF CKD IN CHILDREN

Joseph T Flynn, Nephrologist, Washington DC

1250-1320 NOVEL THERAPY IN IGA NEPHROPATHY

Yusuke Suzuki, Nephrologist, Juntendo University

[APSN Speaker]

1250-1320 LONG TERM SEQUELAE OF ACUTE KIDNEY INJURY

Emily See, Critical Care Nephrologist, Austin Health

1250-1320 UPDATE IN PERITONEAL DIALYSIS

Sunita Bavanandan, Head of Department, Hospital Kuala Lumpur

[APSN Speaker]

1250-1320 ENVIRONMENTALLY FRIENDLY DIALYSIS

Steve May, Tamworth Rural Referral Hospital

1250-1320 UPDATE IN NEPHROTIC SYNDROME IN CHILDREN

Rachael Kermond, Advanced Paediatric Nephrology Trainee, Royal Children’s Hospital, Melbourne

1320-1350 UPDATE IN MANAGEMENT OF ANCA VASCULITIS

Robyn Langham, Monash University

1320-1350 DIAGNOSIS AND MANAGEMENT OF CARDIORENAL SYNDROME

Nathan Dwyer, Cardiologist, Royal Hobart Hospital

1320-1350 ADVANCING INDIGENOUS KIDNEY HEALTH

Suetonia Palm, University of Otago, Christchurch

1320-1350 RECURRENT CEPHALIC ARCH STENOSIS: RISK FACTORS AND BEST OPTIONS FOR MANAGEMENT

Yong-Soo Kim,  Nephrologist, Catholic University of Korea College of Medicine

1320-1350 UPDATE IN UTIs IN PAEDIATRICS

Laila Ibrahim, Murdoch Children’s Research Institute

1355-1415 EXHIBITION & REFRESHMENT BREAK
Take a break, have a stretch, visit the sponsors in the Exhibition Lounge, or connect with a colleague in the Meeting Hub.
1415-1555
CONCURRENT SESSIONS

Each sessions consists of minimum three speakers and question time. Participants may attend any session without pre-booking.  
GLOMERULONEPHRITIS ACUTE KIDNEY INJURY AND ELECTROLYTES CHRONIC KIDNEY DISEASE (CKD) INTERVENTIONAL NEPHROLOGY – ANZSIN / ANZSN combined session PAEDIATRIC / GENETIC NEPHROLOGY – KidGen / ANZSN combined session
1415-1420 CHAIR INTRODUCTION
Muh Geot Wong
1415-1420 CHAIR INTRODUCTION
Robert MacGinley
1415-1420 CHAIR INTRODUCTION
Rob Walker
1415-1420 CHAIR INTRODUCTION
Eddie Tan

GENETIC WORKSHOP 101

Patients with genetic kidney disease benefit from a multidisciplinary approach to assessment and testing. At this workshop you will be taken through worked clinical cases by a team of clinical geneticists, nephrologists and genetic counsellors who will draw on their clinical experience to demonstrate the power of the team based approach. Participants will be introduced to clinical assessment, testing modalities, genomic interpretation, counselling and cascade testing.

 

 

1420-1450 ROLE OF B CELL THERAPY IN GLOMERULONEPHRITIS

Holly Hutton, Nephrologist, Alfred Health, Melbourne

1420-1450 UPDATES ON POTASSIUM AND ADRENALS

Amanda Mather, Nephrologist, Royal North Shore Hospital and University of Sydney

1420-1450 CONSERVATIVE CARE IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Raj Rajesh, Nephrologist, Launceston General Hospital

1420-1450 CARI GUIDELINES FOR KIDNEY BIOPSY

Jeff Wong, Specialist nephrologist, South Western Sydney Local Health District

1420-1450 ROLE OF ENDOTHELIN RECEPTOR ANTAGONIST IN PROTEINURIC KIDNEY DISEASE

Muh Geot Wong, Nephrologist, Royal North Shore Hospital, University of Sydney and UNSW

1420-1450 UPDATE IN ACUTE INTERSTITIAL NEPHRITIS

Robert MacGinley, Nephrologist, Eastern Health Clinical School, Monash University, Melbourne

1420-1450 ASSESSMENT FRAILTY IN PATIENTS WITH CKD – WHAT, WHEN AND HOW?

Kathryn Ducharlet, St Vincent’s Hospital Melbourne

 

1420-1450 IMMATURE FISTULA: CHARACTERISTICS AND OUTCOMES OF ENDOVASCULAR SALVAGE

Yong-Soo Kim, Nephrologist, Catholic University of Korea College of Medicine

1420-1450 UPDATES IN GLOMERULAR DISEASES IN PREGNANCY

Shilpa Jesudason, Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service

1420-1450 COVID 19 AND KIDNEYS

Vivekanand Jha, Nephrologist, The George Institute for Global Health

1420-1450 ROLE OF POTASSIUM AND UREMIC BINDER IN MANAGEMENT OF CKD

Suet Wan Choy, Nephrologist, Austin Health

1420-1450 POINT OF CARE ULTRASOUND

Tim Spicer, Director of renal medicine, South Western Sydney Local Health District

1555 DAY ONE CONCLUDES
Sunday, 29th November 2020
0830-0855
SPEED NETWORKING ICEBREAKER
Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Participants will be randomly allocated through a series of four-person 4 minute video chats.  You never know who you might meet!
TRANSPLANTATION – TSANZ / ANZSN combined

Kidney transplantation is considered the treatment of choice for individuals with severe chronic kidney disease due to improved quality of life and survival when compared to individuals receiving dialysis. This half-day session is a combined effort of TSANZ and ANZSN in providing essential updates on relevant topics for non-transplant nephrologists. This session covers relevant topics in kidney transplantation for donor and recipient perspective, from pre-transplant assessment to post-transplant management as well as the paired kidney exchange program. 

Learning objective(s):

  • To promote understanding and clinical knowledge in advances in kidney transplantation for non-transplant physicians.
  • To outline the current available evidence and gaps in knowledge with view to promote future research directions.
    • The virtual case group discussion with covers clinical scenarios commonly encounter by non-transplant nephrologists while caring for your patients with kidney transplantation.
0855-0930
WHAT DID WE LEARN IN 2020?
0855-0900 WELCOME
Natasha Rogers, Scientific Program & Awards Committee (SPAC) Chair

0900-0930 ADVANCES IN KIDNEY TRANSPLANTATION IN 2020

Jeremy Chapman, Westmead Hospital

0930-1135
PRE-TRANSPLANT
Chair: Natasha Rogers

0930-1000 PRE-TRANSPLANT IMMUNOLOGICAL ASSESSMENT AND MANAGEMENT

Natasha Rogers, Nephrologist, Westmead Clinical School

1000-1030 FRAILTY IN KIDNEY TRANSPLANTATION – WHEN TO SAY NO?

Wai Lim, Nephrologist, Sir Charles Gairdner Hospital

1030-1100 PRE-TRANSPLANT MANAGEMENT OF OVERWEIGHT/OBESITY IN POTENTIAL KIDNEY RECIPIENT

Amanda Robertson, Transplant Surgeon, The Royal Melbourne Hospital

1100-1130 CONTROVERSIES IN LIVING KIDNEY DONATION

Rosemary Masterson, Consultant Nephrologist, Royal Melbourne Hospital

1135-1200 EXHIBITION & REFRESHMENT BREAK
Visit our sponsors in the Exhibition Lounge or catch up with colleagues through the Meeting Hub

1200-1405
POST-TRANSPLANT
Chair: Muh Geot Wong

1200-1230 ACUTE AND CHRONIC ANTIBODY MEDIATED REJECTION – WHAT SHOULD YOU KNOW?

Susan Wan, Nephrologist, Royal North Shore Hospital, and RPA Hospital, University of Sydney

1230-1300 POST-TRANSPLANT RECURRENCE OF PRIMARY DISEASE INCLUDING AHUS

Steve Chadban, Nephrologist, Royal Prince Alfred Hospital, University of Sydney

1300-1330 KIDNEY TRANSPLANT HISTOLOGY 101

Brian Nankiviel, Nephrologist, Westmead Hospital, Sydney

1330-1400 PAIRED KIDNEY EXCHANGE PROGRAM REVIEW

Stella McGinn, Nephrologist, Royal North Shore Hospital

1405-1415 EXHIBITION & REFRESHMENT BREAK
Visit our sponsors in the Exhibition Lounge or catch up with colleagues through the Meeting Hub

1415-1500
VIRTUAL CASE STUDY GROUPS

Interpretation challenges faced by non transplant nephrologists. Coordinated by Natasha Rogers and Sebastian Hutlin

1500 DAY TWO CONCLUDES

Recent Comments
    Categories